Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis.

Pichler A, Khalil M, Langkammer C, Pinter D, Ropele S, Fuchs S, Bachmaier G, Enzinger C, Fazekas F.

Mult Scler. 2017 Oct 1:1352458517736149. doi: 10.1177/1352458517736149. [Epub ahead of print]

PMID:
29027843
2.

Quantitative susceptibility mapping: Report from the 2016 reconstruction challenge.

Langkammer C, Schweser F, Shmueli K, Kames C, Li X, Guo L, Milovic C, Kim J, Wei H, Bredies K, Buch S, Guo Y, Liu Z, Meineke J, Rauscher A, Marques JP, Bilgic B.

Magn Reson Med. 2018 Mar;79(3):1661-1673. doi: 10.1002/mrm.26830. Epub 2017 Jul 31.

PMID:
28762243
3.

Assessment of ferritin content in multiple sclerosis brains using temperature-induced R*2 changes.

Birkl C, Carassiti D, Hussain F, Langkammer C, Enzinger C, Fazekas F, Schmierer K, Ropele S.

Magn Reson Med. 2018 Mar;79(3):1609-1615. doi: 10.1002/mrm.26780. Epub 2017 Jun 15.

PMID:
28618066
4.

Multimodal assessment of white matter tracts in amyotrophic lateral sclerosis.

Borsodi F, Culea V, Langkammer C, Khalil M, Pirpamer L, Quasthoff S, Enzinger C, Schmidt R, Fazekas F, Ropele S.

PLoS One. 2017 Jun 2;12(6):e0178371. doi: 10.1371/journal.pone.0178371. eCollection 2017.

5.

Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.

Burgetova A, Dusek P, Vaneckova M, Horakova D, Langkammer C, Krasensky J, Sobisek L, Matras P, Masek M, Seidl Z.

AJNR Am J Neuroradiol. 2017 Jun;38(6):1079-1086. doi: 10.3174/ajnr.A5166. Epub 2017 Apr 27.

6.

Effects of concentration and vendor specific composition of formalin on postmortem MRI of the human brain.

Birkl C, Soellradl M, Toeglhofer AM, Krassnig S, Leoni M, Pirpamer L, Vorauer T, Krenn H, Haybaeck J, Fazekas F, Ropele S, Langkammer C.

Magn Reson Med. 2018 Feb;79(2):1111-1115. doi: 10.1002/mrm.26699. Epub 2017 Apr 5.

PMID:
28382642
7.

Mechanical characterization of human brain tissue.

Budday S, Sommer G, Birkl C, Langkammer C, Haybaeck J, Kohnert J, Bauer M, Paulsen F, Steinmann P, Kuhl E, Holzapfel GA.

Acta Biomater. 2017 Jan 15;48:319-340. doi: 10.1016/j.actbio.2016.10.036. Epub 2016 Oct 27.

PMID:
27989920
8.

Prognostic value of free light chains lambda and kappa in early multiple sclerosis.

Voortman MM, Stojakovic T, Pirpamer L, Jehna M, Langkammer C, Scharnagl H, Reindl M, Ropele S, Seifert-Held T, Archelos JJ, Fuchs S, Enzinger C, Fazekas F, Khalil M.

Mult Scler. 2017 Oct;23(11):1496-1505. doi: 10.1177/1352458516681503. Epub 2016 Nov 29.

PMID:
27899552
9.

Comment on the letter to the editor entitled "Brain iron deposition in patients with white matter hyperintensities of presumed vascular origin" by D. Zhou.

Gattringer T, Khalil M, Langkammer C, Pinter D, Ropele S, Fazekas F, Enzinger C.

Neurobiol Aging. 2017 May;53:198. doi: 10.1016/j.neurobiolaging.2016.09.026. Epub 2016 Oct 11. No abstract available.

PMID:
27818002
10.

Accelerated mapping of magnetic susceptibility using 3D planes-on-a-paddlewheel (POP) EPI at ultra-high field strength.

Stäb D, Bollmann S, Langkammer C, Bredies K, Barth M.

NMR Biomed. 2017 Apr;30(4). doi: 10.1002/nbm.3620. Epub 2016 Oct 20.

PMID:
27763692
11.

Quantitative Susceptibility Mapping in Parkinson's Disease.

Langkammer C, Pirpamer L, Seiler S, Deistung A, Schweser F, Franthal S, Homayoon N, Katschnig-Winter P, Koegl-Wallner M, Pendl T, Stoegerer EM, Wenzel K, Fazekas F, Ropele S, Reichenbach JR, Schmidt R, Schwingenschuh P.

PLoS One. 2016 Sep 6;11(9):e0162460. doi: 10.1371/journal.pone.0162460. eCollection 2016.

12.

No evidence for increased brain iron deposition in patients with ischemic white matter disease.

Gattringer T, Khalil M, Langkammer C, Jehna M, Pichler A, Pinter D, Kneihsl M, Petrovic K, Ropele S, Fazekas F, Enzinger C.

Neurobiol Aging. 2016 Sep;45:61-63. doi: 10.1016/j.neurobiolaging.2016.05.008. Epub 2016 May 14.

PMID:
27459926
13.

Single-step quantitative susceptibility mapping with variational penalties.

Chatnuntawech I, McDaniel P, Cauley SF, Gagoski BA, Langkammer C, Martin A, Grant PE, Wald LL, Setsompop K, Adalsteinsson E, Bilgic B.

NMR Biomed. 2017 Apr;30(4). doi: 10.1002/nbm.3570. Epub 2016 Jun 22.

14.

Iron quantification with susceptibility.

Ropele S, Langkammer C.

NMR Biomed. 2017 Apr;30(4). doi: 10.1002/nbm.3534. Epub 2016 Apr 27. Review.

PMID:
27119601
15.

Effects of formalin fixation and temperature on MR relaxation times in the human brain.

Birkl C, Langkammer C, Golob-Schwarzl N, Leoni M, Haybaeck J, Goessler W, Fazekas F, Ropele S.

NMR Biomed. 2016 Apr;29(4):458-65. doi: 10.1002/nbm.3477. Epub 2016 Feb 2.

PMID:
26835664
16.

Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.

Khalil M, Renner A, Langkammer C, Enzinger C, Ropele S, Stojakovic T, Scharnagl H, Bachmaier G, Pichler A, Archelos JJ, Fuchs S, Seifert-Held T, Fazekas F.

Mult Scler. 2016 Oct;22(12):1560-1568. Epub 2016 Jan 13.

PMID:
26762671
17.

Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T.

Louapre C, Govindarajan ST, Giannì C, Langkammer C, Sloane JA, Kinkel RP, Mainero C.

Neurology. 2015 Nov 10;85(19):1702-9. doi: 10.1212/WNL.0000000000002106. Epub 2015 Oct 14.

18.

Rapid multi-orientation quantitative susceptibility mapping.

Bilgic B, Xie L, Dibb R, Langkammer C, Mutluay A, Ye H, Polimeni JR, Augustinack J, Liu C, Wald LL, Setsompop K.

Neuroimage. 2016 Jan 15;125:1131-1141. doi: 10.1016/j.neuroimage.2015.08.015. Epub 2015 Aug 12.

19.

Combined analysis of global and compartmental brain volume changes in early multiple sclerosis in clinical practice.

Pichler A, Khalil M, Langkammer C, Pinter D, Bachmaier G, Ropele S, Fuchs S, Enzinger C, Fazekas F.

Mult Scler. 2016 Mar;22(3):340-6. doi: 10.1177/1352458515593405. Epub 2015 Jul 10.

PMID:
26163072
20.

Periventricular lesions correlate with cortical thinning in multiple sclerosis.

Jehna M, Pirpamer L, Khalil M, Fuchs S, Ropele S, Langkammer C, Pichler A, Stulnig F, Deutschmann H, Fazekas F, Enzinger C.

Ann Neurol. 2015 Oct;78(4):530-9. doi: 10.1002/ana.24461. Epub 2015 Jul 28.

PMID:
26084936
21.

Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.

Khalil M, Langkammer C, Pichler A, Pinter D, Gattringer T, Bachmaier G, Ropele S, Fuchs S, Enzinger C, Fazekas F.

Neurology. 2015 Jun 16;84(24):2396-402. doi: 10.1212/WNL.0000000000001679. Epub 2015 May 15.

PMID:
25979698
22.

Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.

Pinter D, Khalil M, Pichler A, Langkammer C, Ropele S, Marschik PB, Fuchs S, Fazekas F, Enzinger C.

Neuroimage Clin. 2015 Mar 5;7:715-20. doi: 10.1016/j.nicl.2015.02.023. eCollection 2015.

23.

Fast quantitative susceptibility mapping using 3D EPI and total generalized variation.

Langkammer C, Bredies K, Poser BA, Barth M, Reishofer G, Fan AP, Bilgic B, Fazekas F, Mainero C, Ropele S.

Neuroimage. 2015 May 1;111:622-30. doi: 10.1016/j.neuroimage.2015.02.041. Epub 2015 Feb 27.

PMID:
25731991
24.

R2* mapping for brain iron: associations with cognition in normal aging.

Ghadery C, Pirpamer L, Hofer E, Langkammer C, Petrovic K, Loitfelder M, Schwingenschuh P, Seiler S, Duering M, Jouvent E, Schmidt H, Fazekas F, Mangin JF, Chabriat H, Dichgans M, Ropele S, Schmidt R.

Neurobiol Aging. 2015 Feb;36(2):925-32. doi: 10.1016/j.neurobiolaging.2014.09.013. Epub 2014 Sep 19.

PMID:
25443291
25.

Functional connectivity analyses using emulated and conventional resting-state data: parts versus the whole story.

Loitfelder M, Pinter D, Langkammer C, Jehna M, Ropele S, Fazekas F, Schmidt R, Enzinger C.

Brain Connect. 2014 Dec;4(10):842-8. doi: 10.1089/brain.2013.0220.

PMID:
25389907
26.

Association between increased magnetic susceptibility of deep gray matter nuclei and decreased motor function in healthy adults.

Li W, Langkammer C, Chou YH, Petrovic K, Schmidt R, Song AW, Madden DJ, Ropele S, Liu C.

Neuroimage. 2015 Jan 15;105:45-52. doi: 10.1016/j.neuroimage.2014.10.009. Epub 2014 Oct 12.

27.

Determinants of iron accumulation in deep grey matter of multiple sclerosis patients.

Ropele S, Kilsdonk ID, Wattjes MP, Langkammer C, de Graaf WL, Frederiksen JL, Larsson HB, Yiannakas M, Wheeler-Kingshott CA, Enzinger C, Khalil M, Rocca MA, Sprenger T, Amann M, Kappos L, Filippi M, Rovira A, Ciccarelli O, Barkhof F, Fazekas F.

Mult Scler. 2014 Nov;20(13):1692-8. doi: 10.1177/1352458514531085. Epub 2014 Apr 30.

PMID:
24787429
28.

Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis.

Khalil M, Riedlbauer B, Langkammer C, Enzinger C, Ropele S, Stojakovic T, Scharnagl H, Culea V, Petzold A, Teunissen C, Archelos JJ, Fuchs S, Fazekas F.

Mult Scler. 2014 Oct;20(12):1569-77. doi: 10.1177/1352458514530020. Epub 2014 Apr 28.

PMID:
24777275
29.

Iron mapping using the temperature dependency of the magnetic susceptibility.

Birkl C, Langkammer C, Krenn H, Goessler W, Ernst C, Haybaeck J, Stollberger R, Fazekas F, Ropele S.

Magn Reson Med. 2015 Mar;73(3):1282-8. doi: 10.1002/mrm.25236. Epub 2014 Apr 17.

PMID:
24752873
30.

Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.

Loitfelder M, Fazekas F, Koschutnig K, Fuchs S, Petrovic K, Ropele S, Pichler A, Jehna M, Langkammer C, Schmidt R, Neuper C, Enzinger C.

PLoS One. 2014 Apr 9;9(4):e93715. doi: 10.1371/journal.pone.0093715. eCollection 2014.

31.

Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis.

Pinter D, Sumowski J, DeLuca J, Fazekas F, Pichler A, Khalil M, Langkammer C, Fuchs S, Enzinger C.

PLoS One. 2014 Jan 27;9(1):e87567. doi: 10.1371/journal.pone.0087567. eCollection 2014.

32.

Assessment of trace elements in human brain using inductively coupled plasma mass spectrometry.

Krebs N, Langkammer C, Goessler W, Ropele S, Fazekas F, Yen K, Scheurer E.

J Trace Elem Med Biol. 2014 Jan;28(1):1-7. doi: 10.1016/j.jtemb.2013.09.006. Epub 2013 Oct 3.

PMID:
24188895
33.

Temperature Dependency of T1 Relaxation Time in Unfixed and Fixed Human Brain Tissue.

Birkl C, Langkammer C, Haybaeck J, Ernst C, Stollberger R, Fazekas F, Ropele S.

Biomed Tech (Berl). 2013 Sep 7. pii: /j/bmte.2013.58.issue-s1-L/bmt-2013-4290/bmt-2013-4290.xml. doi: 10.1515/bmt-2013-4290. [Epub ahead of print] No abstract available.

PMID:
24042944
34.

Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan.

Li W, Wu B, Batrachenko A, Bancroft-Wu V, Morey RA, Shashi V, Langkammer C, De Bellis MD, Ropele S, Song AW, Liu C.

Hum Brain Mapp. 2014 Jun;35(6):2698-713. doi: 10.1002/hbm.22360. Epub 2013 Sep 13.

35.

Time-optimized high-resolution readout-segmented diffusion tensor imaging.

Reishofer G, Koschutnig K, Langkammer C, Porter D, Jehna M, Enzinger C, Keeling S, Ebner F.

PLoS One. 2013 Sep 3;8(9):e74156. doi: 10.1371/journal.pone.0074156. eCollection 2013.

36.

MRI for iron mapping in Alzheimer's disease.

Langkammer C, Ropele S, Pirpamer L, Fazekas F, Schmidt R.

Neurodegener Dis. 2014;13(2-3):189-91. doi: 10.1159/000353756. Epub 2013 Aug 7. Review.

PMID:
23942230
37.

Temperature-induced changes of magnetic resonance relaxation times in the human brain: a postmortem study.

Birkl C, Langkammer C, Haybaeck J, Ernst C, Stollberger R, Fazekas F, Ropele S.

Magn Reson Med. 2014 Apr;71(4):1575-80. doi: 10.1002/mrm.24799. Epub 2013 May 28.

PMID:
23716457
38.

Multicenter R2* mapping in the healthy brain.

Ropele S, Wattjes MP, Langkammer C, Kilsdonk ID, Graaf WL, Frederiksen JL, Fuglø D, Yiannakas M, Wheeler-Kingshott CA, Enzinger C, Rocca MA, Sprenger T, Amman M, Kappos L, Filippi M, Rovira A, Ciccarelli O, Barkhof F, Fazekas F.

Magn Reson Med. 2014 Mar;71(3):1103-7. doi: 10.1002/mrm.24772.

PMID:
23657963
39.

An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in multiple sclerosis.

Jehna M, Langkammer C, Khalil M, Fuchs S, Reishofer G, Fazekas F, Ebner F, Enzinger C.

Brain Connect. 2013;3(3):255-64. doi: 10.1089/brain.2012.0108. Epub 2013 May 7.

PMID:
23573900
40.

Quantitative susceptibility mapping in multiple sclerosis.

Langkammer C, Liu T, Khalil M, Enzinger C, Jehna M, Fuchs S, Fazekas F, Wang Y, Ropele S.

Radiology. 2013 May;267(2):551-9. doi: 10.1148/radiol.12120707. Epub 2013 Jan 11.

41.

Levodopa changes brain motor network function during ankle movements in Parkinson's disease.

Schwingenschuh P, Katschnig P, Jehna M, Koegl-Wallner M, Seiler S, Wenzel K, Ropele S, Langkammer C, Gattringer T, Svehlík M, Ott E, Fazekas F, Schmidt R, Enzinger C.

J Neural Transm (Vienna). 2013 Mar;120(3):423-33. doi: 10.1007/s00702-012-0896-6. Epub 2012 Sep 19.

PMID:
22990677
42.

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.

Khalil M, Enzinger C, Langkammer C, Ropele S, Mader A, Trentini A, Vane ML, Wallner-Blazek M, Bachmaier G, Archelos JJ, Koel-Simmelink MJ, Blankenstein MA, Fuchs S, Fazekas F, Teunissen CE.

Mult Scler. 2013 Apr;19(4):436-42. doi: 10.1177/1352458512458010. Epub 2012 Aug 23.

43.

Differences and similarities in the evolution of morphologic brain abnormalities between paediatric and adult-onset multiple sclerosis.

Pichler A, Enzinger C, Fuchs S, Plecko-Startinig B, Gruber-Sedlmayr U, Linortner P, Langkammer C, Khalil M, Ebner F, Ropele S, Fazekas F.

Mult Scler. 2013 Feb;19(2):167-72. doi: 10.1177/1352458512448107. Epub 2012 Jun 19.

PMID:
22717380
44.

Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study.

Langkammer C, Schweser F, Krebs N, Deistung A, Goessler W, Scheurer E, Sommer K, Reishofer G, Yen K, Fazekas F, Ropele S, Reichenbach JR.

Neuroimage. 2012 Sep;62(3):1593-9. doi: 10.1016/j.neuroimage.2012.05.049. Epub 2012 May 24.

45.

Iron and neurodegeneration in multiple sclerosis.

Khalil M, Teunissen C, Langkammer C.

Mult Scler Int. 2011;2011:606807. doi: 10.1155/2011/606807. Epub 2011 Feb 10.

46.

Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study.

Khalil M, Langkammer C, Ropele S, Petrovic K, Wallner-Blazek M, Loitfelder M, Jehna M, Bachmaier G, Schmidt R, Enzinger C, Fuchs S, Fazekas F.

Neurology. 2011 Nov 1;77(18):1691-7. doi: 10.1212/WNL.0b013e318236ef0e. Epub 2011 Oct 5.

PMID:
21975210
47.

Susceptibility induced gray-white matter MRI contrast in the human brain.

Langkammer C, Krebs N, Goessler W, Scheurer E, Yen K, Fazekas F, Ropele S.

Neuroimage. 2012 Jan 16;59(2):1413-9. doi: 10.1016/j.neuroimage.2011.08.045. Epub 2011 Aug 26.

48.

MRI assessment of iron deposition in multiple sclerosis.

Ropele S, de Graaf W, Khalil M, Wattjes MP, Langkammer C, Rocca MA, Rovira A, Palace J, Barkhof F, Filippi M, Fazekas F.

J Magn Reson Imaging. 2011 Jul;34(1):13-21. doi: 10.1002/jmri.22590. Review.

PMID:
21698703
49.

Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces.

Jehna M, Langkammer C, Wallner-Blazek M, Neuper C, Loitfelder M, Ropele S, Fuchs S, Khalil M, Pluta-Fuerst A, Fazekas F, Enzinger C.

Brain Imaging Behav. 2011 Dec;5(4):241-51. doi: 10.1007/s11682-011-9128-1.

PMID:
21656213
50.

The functional correlates of face perception and recognition of emotional facial expressions as evidenced by fMRI.

Jehna M, Neuper C, Ischebeck A, Loitfelder M, Ropele S, Langkammer C, Ebner F, Fuchs S, Schmidt R, Fazekas F, Enzinger C.

Brain Res. 2011 Jun 1;1393:73-83. doi: 10.1016/j.brainres.2011.04.007. Epub 2011 Apr 9.

PMID:
21513918

Supplemental Content

Loading ...
Support Center